GSK Gsk Plc

TIDMGSK

RNS Number : 4052W

GlaxoSmithKline PLC

16 April 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
      ======================================================================= 
 a)    Name                      Mr S P Dingemans 
====  =========================  ============================================ 
 b)    Position/status           Executive Director 
====  =========================  ============================================ 
 c)    Initial notification/     Initial notification 
        amendment 
====  =========================  ============================================ 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ======================================================================= 
 a)    Name                      GlaxoSmithKline plc 
====  =========================  ============================================ 
 b)    LEI                       5493000HZTVUYLO1D793 
====  =========================  ============================================ 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ======================================================================= 
 a)    Description of             Ordinary shares of 25 pence each ('Ordinary 
        the financial              Shares') 
        instrument                 ISIN: GB0009252882 
====  =========================  ============================================ 
 b)    Nature of the             Acquisition of Ordinary Shares following 
        transaction               the re-investment of dividends paid to 
                                  shareholders on 11 April 2019 on Ordinary 
                                  Shares held in the Company's Performance 
                                  Share Plan, subject to a 2-year holding 
                                  period. 
====  =========================  ============================================ 
 c)    Price(s) and                Price(s)      Volume(s) 
        volume(s)                                ---------- 
                                    GBP15.6560    2220.684 
                                                 ---------- 
                                    GBP15.6560    2397.921 
                                                 ---------- 
====  =========================  ============================================ 
 d)    Aggregated information 
        Aggregated volume          4618.605 
        Price 
                                   GBP15.6560 
====  =========================  ============================================ 
 
 e)    Date of the transaction    2019-04-12 
====  =========================  ============================================ 
 f)    Place of the              London Stock Exchange (XLON) 
        transaction 
====  =========================  ============================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQQLFFKZFFBBK

(END) Dow Jones Newswires

April 16, 2019 12:23 ET (16:23 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024